Search Results 21-30 of 7485 for cf
Vanzacaftor, tezacaftor, and deutivacaftor combination is used to treat cystic fibrosis (CF) in patients who have at least one F508del mutation or another ...
Phase 3 Study With Dual Release Ciprofloxacin for Inhalation in Non-CF Bronchiectasis ... Cystic Fibrosis. Participating Mayo Clinic locations. Study ...
An estimated 30,000 people are living with cystic fibrosis in the U.S. This genetic disease can cause progressive lung damage and recurrent episodes of lung ...
This study will explore the effects of delivering a common nebulized drug taken by Cystic fibrosis (CF) patients during exercise. Participation eligibility.
Research. Mayo Clinic researchers study genetics, causes, diagnostic tests and treatment options for cystic fibrosis. You may have the opportunity to ...
Tezacaftor/ivacaftor and ivacaftor combination is used to treat cystic fibrosis (CF) in patients 6 years of age and older. It is only used for patients who ...
Cystic Fibrosis Pediatric Patients Sinonasal Quality of Life Using Trikafta ... CF patients utilizing validated Sinonasal Quality of Life Survey (SN-5).
The Bronchiectasis Research Registry is a consolidated database of non-cystic fibrosis (non-CF) bronchiectasis patients from major clinical and research ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.